When we think of R&D in a scientific context, we oftentimes tend to picture scientists in lab coats and safety glasses. However, for the IRS, the scope of research is significantly broader and may include efforts and investments made in day-to-day activities. In fact, R&D in pharmaceutical Companies includes a wide spectrum of activities ranging from minor improvements on existing products to the development of new formulas, vaccines, or methods…
At Bonham & Brook, we follow a comprehensive process to ensure that your projects meet the requirements and criteria set by the IRS for the R&D tax credit. Here’s what we evaluate:
It’s worth noting that your project doesn’t have to be successful or fully completed to qualify for the R&D tax credit.
If you answered yes to any of these questions, we encourage you to reach out to us to discuss your eligibility. We’re here to help, even if you’re not sure whether your project qualifies.
Modification of existing processes
Modifications to existing formulas
New Product Development
Please get in touch and a member of our team will get back to you immediately.